早期子宫内膜癌区域淋巴结孤立肿瘤细胞的特征分析
这项回顾性队列研究基于美国国家癌症研究所监测、流行病学和最终结果计划数据,纳入6472例非转移性、淋巴结阴性T1期子宫内膜癌患者,分析区域淋巴结孤立肿瘤细胞(ITC)的特征。结果显示ITC见于1.7%的病例,深肌层浸润和较大肿瘤与ITC风险升高相关,前哨淋巴结活检方案较淋巴结清扫更易识别ITC,ITC阳性者术后治疗率更高。
要点
- 早期子宫内膜癌中ITC发生率为1.7%(111/6472)。
- 深肌层浸润(T1b vs T1a,4.0% vs 1.0%,aOR 3.42)和肿瘤>4 cm(3.0% vs 1.6%,aOR 1.55)与ITC风险升高相关。
- 前哨淋巴结活检方案较淋巴结清扫更易识别ITC(SLN alone 2.7%、SLN/LND 3.7%、LND alone 1.2%,aOR 2.60-2.99)。
核心结论
- 本研究提示前哨淋巴结活检方案可在早期子宫内膜癌区域淋巴结中识别更多ITC。
- 深肌层浸润和较大肿瘤与ITC风险升高相关。
- ITC阳性时术后治疗更频繁,治疗模式多样,需进一步结局研究和实践指南。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症研究所监测、流行病学和最终结果计划数据。
- 研究人群为6472例非转移性、淋巴结阴性T1期子宫内膜癌女性,均接受初次子宫切除术和手术淋巴结评估。
- 采用多变量二元 logistic 回归模型识别ITC的独立特征,并按ITC状态用倾向评分加权评估术后治疗。
主要发现
- ITC见于111例(1.7%)。
- 多变量分析中,深肌层浸润(T1b vs T1a,4.0% vs 1.0%,aOR 3.42,P < 0.001)和肿瘤>4 cm(>4 vs ≤4 cm,3.0% vs 1.6%,aOR 1.55,P = 0.037)与ITC相关。
- 前哨淋巴结活检方式与ITC识别相关:SLN alone 2.7%、SLN/LND 3.7%、LND alone 1.2%(aOR 范围2.60-2.99,P < 0.001)。
- ITC阳性女性更可能接受术后治疗(81.8% vs 31.7%,P < 0.001),包括单独体外放疗(25.1% vs 3.2%)和化疗/体外放疗(16.3% vs 1.9%)。
- 低危组(IA期、1-2级子宫内膜样癌)中观察到类似关联(78.4% vs 9.2%,P < 0.001),包括单独体外放疗(35.3% vs 0.6%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需进一步结局研究和实践指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the characteristics of isolated tumor cells (ITCs) in regional lymph nodes of early-stage endometrial cancer. METHODS: This is a retrospective cohort study examining the National Cancer Institute's Surveillance, Epidemiology, and End Result Program. The study population was 6472 women with non-metastatic, node-negative T1 endometrial cancer who underwent primary hysterectomy and surgical nodal evaluation. Multivariable binary logistic regression model was used to identify the independent characteristics for ITCs. Postoperative therapy according to ITCs status was also assessed with propensity score weighting. RESULTS: ITCs were seen in 111 (1.7%) cases. In a multivariable analysis, ITCs were largely associated with tumor factors including deep myometrial invasion (T1b versus T1a, 4.0% versus 1.0%, adjusted-odds ratio [aOR] 3.42, P < 0.001) and larger tumor size (>4 versus ≤4 cm, 3.0% versus 1.6%, aOR 1.55, P = 0.037). Moreover, women undergoing sentinel lymph node (SLN) biopsy had a higher likelihood of identifying ITCs compared to those undergoing lymphadenectomy (LND): 2.7% for SLN alone, 3.7% for SLN/LND, and 1.2% for LND alone (aOR ranged 2.60-2.99, P < 0.001). Women who had ITCs identified were more likely to receive postoperative therapy (81.8% versus 31.7%, P < 0.001), including external beam radiotherapy (EBT) alone (25.1% versus 3.2%) and chemotherapy/EBT (16.3% versus 1.9%). Similar associations were observed in the low-risk group (stage IA, grade 1-2 endometrioid, 78.4% versus 9.2%, P < 0.001), including EBT alone (35.3% versus 0.6%). CONCLUSION: This study suggests that a SLN protocol can identify more ITCs in the regional lymph nodes of early endometrial cancer. Deep myometrial invasion and large tumor size were associated with increased risk of ITCs. Postoperative therapy is offered more frequently in the setting of ITCs with variable treatment patterns, warranting further outcome studies and practice guidelines.
引用
- Matsuo K, Khetan VU, Brunette LL, et al. Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer. Gynecol Oncol. 2022. PMID: 35232589. doi:10.1016/j.ygyno.2022.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。